No recorded roll-call vote on this bill yet
The HER Act directs the Secretary of Health and Human Services to award grants for research, investigation, and awareness of how personal care products containing endocrine-disrupting chemicals affect the female reproductive system.
Sec. 2, Research grants: The Secretary, through the National Institute of Environmental Health Sciences, must award grants for research on the impact of personal care products with endocrine-disrupting chemicals on the female reproductive system and related reproductive toxicity. Within 5 years of enactment and every 5 years thereafter, the Secretary must report to Congress and publicly on research developments, disparities in access to safe products, lists of safe and harmful products, and strategies to expand FDA regulation of such chemicals.
Sec. 2, State grants for investigation and awareness: The Secretary must award grants to states for programs investigating the impact of these products on women's reproductive health and for public awareness campaigns about safer alternatives. Within 5 years of the first grants and every 5 years thereafter, the Secretary must report to Congress and publicly on the findings and results of these programs.
Sec. 2, Definitions: An endocrine-disrupting chemical mimics, blocks, or interferes with hormones. A personal care product is a cosmetic intended for hygiene, grooming, or personal care. The Secretary is the Secretary of Health and Human Services. A State includes U.S. states, territories, the District of Columbia, and Indian Tribes or Tribal organizations.
Summary of the bill text as introduced in House (Jun 5, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.
No amendments offered
No cost estimate or committee report yet
No related bills listed
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.